Abstract
Sterol regulatory element-binding proteins (SREBPs) regulate homeostasis of LDL, HDL and triglycerides. This study was aimed to determine if inhibition of SREBPs by methyl protodioscin (MPD) regulates downstream gene and protein expressions of lipid metabolisms. In THP-1 macrophages, MPD increases levels of ABCA1 mRNA and protein in dose- and time-dependent manners, and apoA-1-mediated cholesterol efflux. The underlying mechanisms for the effects is that MPD inhibits the transcription of SREBP1c and SREBP2, and decreases levels of microRNA 33a/b hosted in the introns of SREBPs, which leads to reciprocally increase ABCA1 levels. In HepG2 cells, MPD shows the same effects as these observed in THP-1 macrophages. MPD also decreases the gene expressions of HMGCR, FAS and ACC for cholesterol and fatty acid synthesis. MPD further promotes LDL receptor through reducing the PCSK9 level. Collectively, the study demonstrates that MPD potentially increase HDL cholesterol while reducing LDL cholesterol and triglycerides.
References
May 1, 1977·The American Journal of Medicine·T GordonT R Dawber
Jan 1, 1989·Circulation·D J GordonH A Tyroler
Apr 4, 1986·Science·M S Brown, J L Goldstein
Jan 26, 1996·Atherosclerosis·B LamarcheP J Lupien
Nov 23, 2000·Genes & Development·J R SchultzB Shan
Jan 12, 2002·Biochemical and Biophysical Research Communications·Guorong Lin, Karin E Bornfeldt
Jul 5, 2002·The Journal of Biological Chemistry·Aldo GrefhorstFolkert Kuipers
Aug 19, 2003·Journal of Lipid Research·Jeffrey W ChisholmRichard M Lawn
Jan 18, 2006·Cell·Joseph L GoldsteinMichael S Brown
May 11, 2010·Lancet·UNKNOWN Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors CollaborationJohn Danesh
May 15, 2010·Science·S Hani Najafi-ShoushtariAnders M Näär
May 15, 2010·Science·Katey J RaynerCarlos Fernández-Hernando
Jan 5, 2011·Cell Metabolism·Jing-Jie TangBao-Liang Song
Mar 2, 2011·Cell Metabolism·Guido T Bommer, Ormond A MacDougald
Jan 5, 2014·Circulation Research·Katey J Rayner, Kathryn J Moore
Dec 30, 2014·Atherosclerosis·Hagai TavoriSergio Fazio
Citations
May 30, 2015·Expert Opinion on Drug Discovery·Yu DuBin Hong
May 24, 2016·EBioMedicine·Hong TangWeizhen Zhang
Oct 27, 2015·Biomarkers in Medicine·Igor KoturbashBaitang Ning
Sep 1, 2015·Atherosclerosis·Wenhua ZhaoAndreas Ritsch
May 27, 2016·Journal of Natural Products·Yun-Lung ChungChieh-Hsi Wu
Mar 18, 2016·PloS One·Weilie MaZhizhen Zhang
May 19, 2017·The American Journal of Chinese Medicine·Sun Haeng ParkHo Kyoung Kim
Nov 2, 2017·Bioscience, Biotechnology, and Biochemistry·Myung-Ji KangMun-Ock Kim
Apr 4, 2017·Cardiovascular Therapeutics·Su-Jie JiaMing Zhao
Mar 13, 2018·Frontiers in Endocrinology·Shuli YangRuixin Lin
Nov 18, 2018·Frontiers in Pharmacology·Liping QuWenjun Zou
Jan 15, 2020·Pharmaceutical Medicine·Dmitry Y LitvinovAlexander D Dergunov
Jan 20, 2021·Phytotherapy Research : PTR·Saba SoltaniAmirhossein Sahebkar
Dec 6, 2019·Journal of Ethnopharmacology·Dongdong WangVerena M Dirsch
Feb 28, 2020·Ecotoxicology and Environmental Safety·Anouar FerianiMohamed Salah Allagui
Dec 19, 2017·International Immunopharmacology·Jing LiYong-Xiao Cao
Jul 31, 2021·Phytotherapy Research : PTR·Meiao TanHuabao Liu